| scholarly article | Q13442814 |
| P50 | author | Veronica S Hughes | Q87821200 |
| P2093 | author name string | Dietmar W Siemann | |
| Jennifer M Wiggins | |||
| P2860 | cites work | Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors | Q77729027 |
| Influence of the hypoxic subvolume on the survival of patients with head and neck cancer | Q77936400 | ||
| THE INFLUENCE OF ANEMIA ON THE RESULTS OF RADIOTHERAPY IN CARCINOMA OF THE CERVIX | Q78291367 | ||
| Some Aspects of the Effect of Ionizing Radiation on Tumors in Experimental Animals | Q78911449 | ||
| FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer | Q79905758 | ||
| The effect of smoking status on survival following radiation therapy for non-small cell lung cancer | Q80081395 | ||
| Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells | Q80497165 | ||
| Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial | Q83906570 | ||
| VEGF-associated tyrosine kinase inhibition increases the tumor response to single and fractionated dose radiotherapy | Q83917113 | ||
| Acute versus chronic hypoxia: why a simplified classification is simply not enough | Q84387427 | ||
| Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer | Q84582433 | ||
| Hypoxic prostate/muscle PO2 ratio predicts for outcome in patients with localized prostate cancer: long-term results | Q85069799 | ||
| The role of pericytes in blood-vessel formation and maintenance | Q24683881 | ||
| Relating oxygen partial pressure, saturation and content: the haemoglobin-oxygen dissociation curve | Q26775258 | ||
| The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? | Q26823489 | ||
| Immune Checkpoint Blockade in Cancer Therapy | Q26830509 | ||
| Targeting HIF-1 for cancer therapy | Q27860504 | ||
| Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults | Q28005550 | ||
| Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation | Q28204294 | ||
| Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts | Q28256408 | ||
| Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group | Q28282755 | ||
| Tirapazamine: a novel agent targeting hypoxic tumor cells | Q28302710 | ||
| Drug penetration in solid tumours | Q29614404 | ||
| Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions | Q30449383 | ||
| Noradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases | Q30674169 | ||
| Efficacy and Mechanisms of Aerobic Exercise on Cancer Initiation, Progression, and Metastasis: A Critical Systematic Review of In Vivo Preclinical Data | Q31112729 | ||
| pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the pu | Q33289243 | ||
| PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation | Q33569771 | ||
| Hypoxia inducible factors in cancer stem cells | Q33708114 | ||
| The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture. | Q33800899 | ||
| Effect of a topical vasodilator on tumor hypoxia and tumor oxygen guided radiotherapy using EPR oximetry | Q33882791 | ||
| Cardiovascular Late Effects and Exercise Treatment in Breast Cancer: Current Evidence and Future Directions | Q33907581 | ||
| Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation | Q34028645 | ||
| Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations | Q34031084 | ||
| Targeting hypoxic tumour cells to overcome metastasis. | Q34086671 | ||
| The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents | Q34122191 | ||
| RBE and OER within the spread-out Bragg peak for proton beam therapy: in vitro study at the Proton Medical Research Center at the University of Tsukuba | Q34366604 | ||
| Pro-inflammatory cytokines and adipose tissue | Q34420482 | ||
| HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. | Q34471121 | ||
| Action of x-rays on mammalian cells | Q34648824 | ||
| Hypoxia and radiation therapy: past history, ongoing research, and future promise | Q34986265 | ||
| ARCON: a novel biology-based approach in radiotherapy | Q35021325 | ||
| OXYGEN TOXICITY. | Q53978277 | ||
| The Phenomenon of Reoxygenation and Its Implications for Fractionated Radiotherapy | Q54193087 | ||
| Role of Oxygen in Modifying the Radiosensitivity of E. Coli B | Q59074413 | ||
| Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer | Q59363659 | ||
| Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival | Q59647330 | ||
| Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) | Q64390275 | ||
| Hypoxic cell sensitizers for radiotherapy | Q67294358 | ||
| Smoking: the influence of carboxyhemoglobin (HbCO) on tumor oxygenation and response to radiation | Q67404508 | ||
| Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy | Q68327742 | ||
| Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells | Q69246621 | ||
| A Posteffect of Oxygen in Irradiated Bacteria: A Submillisecond Fast Mixing Study | Q69260410 | ||
| The influence of initial hemoglobin and blood pressure levels on results of radiation therapy for carcinoma of the prostate | Q69599990 | ||
| Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C | Q69974067 | ||
| Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements | Q70168020 | ||
| Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix | Q71545581 | ||
| Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck | Q71877350 | ||
| Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing | Q72031099 | ||
| The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing | Q72141361 | ||
| Intercapillary distance, oxygen tension and local recurrence in cervix cancer | Q72244042 | ||
| Oxygen effect factor and tumor volume in the C3H mouse mammary carcinoma. A preliminary report | Q72753269 | ||
| Pentoxifylline improves the oxygenation and radiation response of BA1112 rat rhabdomyosarcomas and EMT6 mouse mammary carcinomas | Q73223514 | ||
| The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy | Q73326377 | ||
| Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers | Q73548714 | ||
| Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance of drug dose and timing | Q74019858 | ||
| Radiobiological hypoxia in the KHT sarcoma: predictions using the Eppendorf histograph | Q74434859 | ||
| Definitive radiotherapy combined with high-dose-rate brachytherapy for Stage III carcinoma of the uterine cervix: retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters | Q74601281 | ||
| The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities | Q77402853 | ||
| A model system for examining the radiosensitivity of metabolising layers of cells | Q39982756 | ||
| The hypoxic tumor cell: a target for selective cancer chemotherapy | Q40281971 | ||
| Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review | Q40405347 | ||
| Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma | Q40577663 | ||
| Increased radiosensitivity with chronic hypoxia in four human tumor cell lines | Q40697887 | ||
| Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids | Q41248289 | ||
| Mechanisms of transfusion-associated immunosuppression | Q41644441 | ||
| Hypoxia regulates SOX2 expression to promote prostate cancer cell invasion and sphere formation | Q41991455 | ||
| Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix | Q42619534 | ||
| Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma | Q42855209 | ||
| Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode | Q42910923 | ||
| Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation | Q43756144 | ||
| Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles. | Q43760423 | ||
| Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours | Q44514473 | ||
| Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis | Q44975603 | ||
| The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers | Q44986233 | ||
| pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia | Q45103730 | ||
| The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcoma | Q45105853 | ||
| Pretreatment and midtreatment measurement of oxygen tension levels in head and neck cancers | Q46076807 | ||
| Repair of radiation induced damage--dependence on oxygen and energy status | Q46227545 | ||
| Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix | Q46926510 | ||
| Tumor size and oxygenation are independent predictors of nodal diseases in patients with cervix cancer | Q47200841 | ||
| Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. | Q48019142 | ||
| Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings | Q49028556 | ||
| Exercise and the Tumor Microenvironment: Potential Therapeutic Implications | Q49797060 | ||
| A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. | Q50561584 | ||
| Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. | Q50649984 | ||
| Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat Cancer. | Q51795514 | ||
| Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. | Q52542582 | ||
| FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial. | Q53136257 | ||
| Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. | Q53204531 | ||
| Carbogen breathing combined with radical radiotherapy in advanced head and neck cancer patients with severe co-morbidities. | Q53605214 | ||
| Immunohistochemical assessment of intrinsic and extrinsic markers of hypoxia in reproductive tissue: differential expression of HIF1α and HIF2α in rat oviduct and endometrium. | Q35106512 | ||
| Impact of hypoxia on the metastatic potential of human prostate cancer cells | Q35186588 | ||
| Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation. | Q35259306 | ||
| Hypoxic gene expression and metastasis | Q35805259 | ||
| Modulation of the tumor vasculature and oxygenation to improve therapy | Q35920685 | ||
| SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours | Q35976983 | ||
| Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label | Q35992147 | ||
| Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity | Q36081569 | ||
| Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and nec | Q36311491 | ||
| Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa | Q36339991 | ||
| Hyperbaric oxygen therapy and cancer--a review | Q36434876 | ||
| Applicability of animal tumor data to cancer therapy in humans | Q36445183 | ||
| Intermittent blood flow in a murine tumor: radiobiological effects | Q36481293 | ||
| Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise. | Q36770262 | ||
| Hypoxia and metastasis in breast cancer. | Q36808477 | ||
| Hypoxic radiosensitization: adored and ignored | Q36935082 | ||
| Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. | Q37084096 | ||
| Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry | Q37113797 | ||
| The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer | Q37299263 | ||
| The relevance of a hypoxic tumour microenvironment in prostate cancer | Q37627310 | ||
| Modelling of the oxygen enhancement ratio for ion beam radiation therapy | Q37871737 | ||
| Imaging hypoxia to improve radiotherapy outcome | Q38059626 | ||
| Prognostic factors in patients with bladder carcinoma treated with definitive irradiation | Q38138805 | ||
| Tumor hypoxia as a driving force in genetic instability. | Q38155002 | ||
| How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture | Q38155899 | ||
| Gene Expression Signatures as Biomarkers of Tumour Hypoxia | Q38568536 | ||
| Hypoxia and Predicting Radiation Response | Q38588997 | ||
| Antiangiogenic therapy in oncology: current status and future directions | Q38725587 | ||
| Radiotherapy in the age of cancer immunology: Current concepts and future developments. | Q38742020 | ||
| Cancer Statistics, 2017. | Q39038674 | ||
| Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy | Q39061401 | ||
| Tumor angiogenesis and vascular normalization: alternative therapeutic targets | Q39403862 | ||
| Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescense based fiber-optic probes | Q39549694 | ||
| Carbogen breathing during radiation therapy The radiation therapy oncology group study | Q39717134 | ||
| The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanisms | Q39725867 | ||
| The histological structure of some human lung cancers and the possible implications for radiotherapy | Q39979244 | ||
| P433 | issue | 1093 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 20170955 | |
| P577 | publication date | 2018-03-14 | |
| P1433 | published in | British Journal of Radiology | Q15758529 |
| P1476 | title | Tumor oxygenation and cancer therapy-then and now | |
| P478 | volume | 92 |
| Q59791856 | Hyperoxygenation as a Therapeutic Supplement for Treatment of Triple Negative Breast Cancer |
| Q56378964 | Hypoxia and IF₁ Expression Promote ROS Decrease in Cancer Cells |
| Q99630614 | Inside the hypoxic tumour: reprogramming of the DDR and radioresistance |
| Q94293799 | Pushing the frontiers of radiobiology: A special feature in memory of Sir Oliver Scott and Professor Jack Fowler |
| Q94547387 | Signaling in and out: long-noncoding RNAs in tumor hypoxia |
| Q90449093 | The Different Routes to Metastasis via Hypoxia-Regulated Programs |
Search more.